Immatics (IMTX) announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer, effective immediately. Dr. Ramanan joins Immatics from Anthos Therapeutics, a Novartis (NVS) company, where he served as CFO. He will succeed Immatics’ current CFO, Arnd Christ.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMTX: